COVID-19：3000 日元辉瑞疫苗：成本 113 日元
-英国媒体震惊-
美国制药公司辉瑞：
研发制造新型冠状病毒疫苗的巨头。
美国制药公司辉瑞
使用保密合同，
据说是在吞噬利润。
提出了一个指示。
英文报纸Guardian Sunday版
观察者
12月5日，辉瑞单支疫苗的成本仅为76便士（113日元）。
辉瑞以 22 英镑的价格出售。
该报告引自一位英国生物技术人员的分析。
守护者分析：
辉瑞因此获得了“利润”。
“这是由于保密协议条款，”卫报分析道。
保密协议条款：
英国政府与辉瑞合作，
签订1.89亿支新型冠状病毒疫苗合同。
我们已经同意保密条款。
美国消费者权益保护组织
公民
“辉瑞的合同中有一个‘秘密障碍’，”Zain Lizbi 说。
在公共卫生危机的背景下，这是不可接受的。”
赞恩·里兹比 (Zain Rizbi) 的主张：
英国必须解释为什么它同意与辉瑞的保密条款。
英国是唯一一个同意与辉瑞签署保密条款的发达国家。
辉瑞公司辩称：
不过，他辩称，“辉瑞没有包括针对这一点的各种成本。”
观察员的估计成本不包括研究等其他成本。
“新型冠状病毒疫苗的税前利润率只有 20% 左右，”他坚称。
中央日报 |
https://s.japanese.joins.com/JArticle/285421?sectcode=A00&servcode=A00
Wall of secrecy’ in Pfizer contracts as company accused of profiteering
Ministers have agreed
a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britain’s Covid vaccine supply.
Large portions of the government’s contracts with the company
over the supply of 189m vaccine doses have been redacted and any arbitration proceedings will be kept secret.
The revelation comes
as Pfizer is accused by a former senior US health official of “war profiteering’’ during the pandemic.In a Channel 4 Dispatches investigation to be broadcast this week,
Tom Frieden, who was director of the US Centers for Disease Control and Prevention under Barack Obama, said:
“If you’re just focusing on maximising your profits and you’re a vaccine manufacturer … you are war profiteering.”
Zain Rizvi, research director at Public Citizen, a US consumer advocacy organisation
which has examined Pfizer’s global vaccine contracts, said:
“There is a wall of secrecy surrounding these contracts and it’s unacceptable, particularly in a public health crisis.”
Rizvi said
the UK needed to explain why it had agreed to secret arbitration proceedings.He said:
It’s the only high-income country we have seen that has agreed to this provision.
It allows pharmaceutical companies to bypass domestic legal processes.
The Channel 4 investigation
reveals analysis by one biological engineering expert claiming the Pfizer vaccine costs just 76p to manufacture for each shot.
It is reportedly being sold for £22 a dose to the UK government.
The estimated manufacturing costs do not include research, distribution and other costs,
but Pfizer says its profit margin as a percentage before tax are in the “high-20s”.
Pfizer expects to deliver 2.3bn vaccines this year with predicted revenues of $36bn (£26.3bn).
UK news | The Guardian